COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRC
MedImmune LLC
MedImmune LLC
Eli Lilly and Company
Freenome Holdings Inc.
NantCell, Inc.
Tempus AI
Elicio Therapeutics
Eli Lilly and Company
Palleon Pharmaceuticals, Inc.
Hoffmann-La Roche
Hutchmed
Intensity Therapeutics, Inc.
Hutchmed
NantBioScience, Inc.
NantCell, Inc.
NextCure, Inc.
ADC Therapeutics S.A.
Isofol Medical AB
pharmaand GmbH
Check-Cap Ltd.
Eisai Inc.
Amgen
Amgen
Imunon
Amgen
Gradalis, Inc.
Jazz Pharmaceuticals
Takeda
SillaJen, Inc.
Isofol Medical AB
Eli Lilly and Company
Eli Lilly and Company
Sirtex Medical
Pfizer
Novadaq Technologies ULC, now a part of Stryker
AbbVie
Amgen
Amgen
Amgen
Generic Devices Consulting, Inc.
Norgine
MediGene
Amgen
EndoAid
Sanofi
Sanofi
Novartis
Hoffmann-La Roche
Amgen
Amgen
Merck Sharp & Dohme LLC